Read the following scenario and use it to answer this question and the following question.

On Sept 18, 2015 Firstpost reported(Links to an external site.):

The Delhi government's directive to cap the cost of laboratory tests for dengue has upset owners of private hospitals and diagnostic clinics. According to the directive, private healthcare establishments can charge a maximum of Rs 600 for NS1 antigen and dengue antibody tests. Platelet count tests should cost no more than Rs 50.

Accusing the government of announcing the figure without taking them into confidence, the private players maintain that the cap is 'unrealistic' since it does not cover even the cost of raw material used. They say they are not being provided with extraction kits and other agents used for laboratory examination on subsidized prices.

Meanwhile, dengue has assumed an epidemic proportion with 1,900 cases and 16 confirmed deaths reported till September 17. Private laboratories are currently charging anywhere between Rs 900 and Rs 2000 for the dengue test while checking platelet count costs about Rs 200.

(Source: "As dengue assumes epidemic proportion, Delhi govt and private players bicker over test price cap", Firstpost.com, 18 Sep 2015.)

Suppose that the (short-run) demand and supply of dengue tests in Delhi is as given below:

Demand: P = 2600 - 0.001Q

Supply: P = 200 + 0.001Q

where P is the price in Rupees/test, and Q is quantity measured in number of tests per month.

Then consider the imposition of a price ceiling of 600 Rupees/test. Which of the following statements is/are true? (Check all of the answers that are correct--there MAY be more than one.)

Group of answer choices

The number of dengue tests sold/transacted per month goes down following the imposition of the price cap.

The price paid perdengue testbyconsumers goes up after the imposition of the price ceiling.

The deadweight loss due to the price ceiling is Rs 640 million per month.

The deadweight loss due to the price ceiling is Rs 1280 million per month.